Saturday, 12 July, 2025

01 Jul 2006 | Australasian Dental Practice

news > Spectrum > Page 40

Patient compliance the key to treating OSA

Obstructive Sleep Apnoea (OSA) syndrome is a very common disorder, affecting approximately 4% of men and 2% of women in the middle-aged workforce. The hallmark repetitive narrowing of the pharynx during sleep and consequent sleep fragmentation and oxygen desaturation, lead to numerous short and long term sequelae.


The immediate effects of this disorder are excessive daytime sleepiness and deficits in neurocognitive performance, both of which directly impact on quality of life as well as having implications for safety (e.g. driving). In the longer term, there is growing evidence that untreated OSA increases the risk of cardiovascular morbidity and mortality, through conditions such as hypertension, myocardial infarction, and stroke.

More recently, with an emerging epidemic of obesity and diabetes, potentially important links to OSA are receiving attention. The high prevalence and significant health consequences of the disorder give rise to a major public health problem, and the financial burden of OSA and related sleep disorders has been recognised.

Lifestyle changes, such as weight loss, avoidance of alcohol and positional changes in bed may assist in the treatment of snoring, although OSA is more difficult to treat in this manner. The standard treatment - continuous positive airway pressure (CPAP) - has been demonstrated to provide major clinical benefit to patients with OSA. In particular, clinical trials have identified a significant reduction in daytime sleepiness, improvement in neurocognitive performance and quality of life, and small but clinically important reductions in blood pressure. Longer-term benefits on cardiovascular risk factors remain to be shown. These benefits are most evident in patients with more severe forms of the disorder.

In milder disease, it seems that the benefits of alleviating OSA are offset by the obtrusive nature of CPAP therapy. Hence, whilst CPAP it is an extremely efficacious treatment in patients who use it, its effectiveness in the clinical setting is hampered by low rates of compliance. This is largely related to difficulties with tolerance and side-effects. Research studies indicate that patients who continue to use CPAP average only 4-5 hours per night, on approximately 70% of nights, which is unlikely to be sufficient to optimise clinical benefit. More problematical is that large, but unspecified, numbers are known to have abandoned CPAP treatment altogether. Consequently, there are concerns that as many as half of mild to moderate OSA patients may no longer be receiving appropriate treatment.

These difficulties with CPAP therapy have initiated a search for simpler and effective treatment alternatives. An important alternative is oral appliance therapy, usually in the form of mandibular advancement splints (MAS). The growing enthusiasm for their use in clinical practice is supported by research evidence showing that such treatment can be used to effectively manage a substantial number of OSA patients, particularly with mild to moderate OSA.

Beyond improvements in symptoms such as snoring, witnessed apnoeas and daytime sleepiness, early studies have identified a positive effect on blood pressure and aspects of neurocognitive performance, similar to that seen with CPAP therapy. Recently updated practice parameters from the American Academy of Sleep Medicine recognise the important role of this treatment and endorse MAS devices as an alternative treatment to CPAP.

A number of rigorous clinical studies have directly compared MAS and CPAP, and whilst CPAP is more efficacious at reducing sleep-disordered breathing, the health benefits of the respective treatments appear to be similar. Importantly, oral appliances tend to be preferred by patients, and this has potentially important implications for treatment compliance and long term health benefits.

Techniques

Surgery Design

Clinical

Abstracts

Stream the latest dental videos...
COVID-19 update: 16 March 2020

Sponsored Links...

Upcoming Events...

Jan 01 2025
Jul 22 2025
Aug 01 2025
Aug 07 2025
Aug 07 2025

IndoHealthcare Expo 2025

Jakarta, INDONESIA

Aug 22 2025

HKIDEAS 2025

Hong Kong, HONG KONG

Aug 28 2025

ABSO Meeting 2025

Hamilton Island, AUSTRALIA

Sep 03 2025

AAPD 2025

Kuta, INDONESIA

Sep 09 2025
Sep 11 2025

Veneers: A Comprehensive Guide

Auckland, NEW ZEALAND

Sep 12 2025
Sep 13 2025
Sep 17 2025

PharMed Cambodia 2025

Phnom Penh, CAMBODIA

Sep 19 2025
Sep 20 2025
Sep 25 2025
Sep 29 2025

PACK EXPO Las Vegas 2025

Las Vegas, USA

Oct 02 2025

IAO 2025

Padova, ITALY

Oct 02 2025

ITI Congress Brazil

Rio de Janeiro, BRAZIL

Oct 09 2025

Pragodent 2025

Prague, CZECH REPUBLIC

Oct 15 2025
Oct 16 2025
Oct 16 2025

DDS Global Congress 2025

Venice, ITALY

Oct 16 2025

OHAA 2025 National Congress

Gold Coast, AUSTRALIA

Oct 24 2025
Nov 05 2025

ITI Congress Mexico

Mérida, MEXICO

Nov 06 2025
Nov 07 2025

ITI Congress Italy

Bologna, ITALY

Nov 08 2025

CDSS 2025

Singapore, SINGAPORE

Nov 14 2025
Nov 20 2025
Nov 28 2025
Dec 05 2025

8th Dental Expo 2025

Lahore, PAKISTAN

Mar 20 2026
Apr 17 2026

IDEM Singapore 2026

Singapore, SINGAPORE

Nov 27 2026
Nov 26 2027
Nov 24 2028